BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 16315894)

  • 61. [TS-1/CDDP/Lentinan combination chemotherapy for inoperable advanced gastric cancer].
    Nagahashi S; Suzuki H; Nishiwaki M; Okuda K; Kurosawa Y; Terada S; Sugihara T; Andou K; Hibi T
    Gan To Kagaku Ryoho; 2004 Nov; 31(12):1999-2003. PubMed ID: 15570928
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [A long-surviving patient with unresectable advanced gastric cancer treated with S-1 and biweekly paclitaxel combination chemotherapy as second-line treatment].
    Oneyama M; Sekikawa K; Goto M; Kitamura M; Kawahara Y; Ohta R; Takahashi Y; Hirata Y; Nakayama M; Shimoda Y
    Gan To Kagaku Ryoho; 2012 Jul; 39(7):1131-3. PubMed ID: 22790054
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [TS-1 treatment for progressive gastric cancer in a patient on chronic dialysis--assessment of dosage regimen by monitoring blood concentrations of therapeutic drugs (TDM)].
    Tanaka T; Fujita S; Tanaka N; Ooka M; Okajima S; Tanaka N
    Gan To Kagaku Ryoho; 2005 Jun; 32(6):841-5. PubMed ID: 15984528
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [A clinical results of TS-1 in advanced and recurrent gastric cancer in our hospital].
    Abe S; Kojima M; Tamura H; Kurihara H; Kitago M; Kobayashi T; Nakamura T; Ogihara T
    Gan To Kagaku Ryoho; 2003 Jul; 30(7):963-70. PubMed ID: 12894711
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [A case of complete remission of carcinomatous ascites refractory for TS-1 monotherapy treated with TS-1 plus paclitaxel combined therapy for gastric cancer].
    Imamura H; Furukawa H; Kishimoto T; Miyazaki Y; Yamamoto K; Ohshiro R; Ohta K; Nakata Y; Kamigaki S; Kondo M; Takemoto H; Fujimi S; Nakayama T; Fukunaga M; Ohsato H; Tatsuta M
    Gan To Kagaku Ryoho; 2006 Nov; 33(12):1900-3. PubMed ID: 17212141
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Two cases of advanced and recurrent gastric cancer treated with the combination of chemotherapy and radiation].
    Fujiwara Y; Miyata H; Takiguchi S; Yasuda T; Yano M; Monden M
    Gan To Kagaku Ryoho; 2004 Oct; 31(11):1876-8. PubMed ID: 15553745
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Results of treatment of far advanced and recurrent stomach cancer with TS-1].
    Johira H; Yunoki S; Kawata N; Watanabe N; Hachisuka Y; Kimura M; Uomoto M; Hatano H; Sanada E; Watanabe R; Ohmori K; Miyata N
    Gan To Kagaku Ryoho; 2005 Feb; 32(2):195-9. PubMed ID: 15751632
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [A case of paclitaxel-resistant cancerous ascites secondary to gastric carcinoma responding well to TS-1 therapy].
    Hara A; Tsunemi S; Yamamoto M; Izumi N; Iwamoto S
    Gan To Kagaku Ryoho; 2006 Dec; 33(13):2065-7. PubMed ID: 17197755
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [A new therapeutic approach to advanced and recurrent gastric cancer by TS-1].
    Yoshida K; Nishimoto N; Kagawa Y; Hihara J; Inoue H; Kim R; Hirai T; Nishiyama M; Toge T
    Gan To Kagaku Ryoho; 2001 Oct; 28(10):1403-12. PubMed ID: 11681248
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [An effective treatment by chemotherapy with S-1 and CDDP intraperitoneal administration for the peritoneal dissemination of gastric cancer--a case report].
    Kadono M; Iwasaki Y; Ohashi M; Iwanaga T; Ohinata R; Takahashi K; Yamaguchi T; Matsumoto H; Nakano D
    Gan To Kagaku Ryoho; 2010 Nov; 37(12):2442-4. PubMed ID: 21224600
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Efficacy of weekly administration of paclitaxel for advanced or recurrent gastric cancer with peritoneal dissemination].
    Hikino H; Yamada T; Hata T; Nakamura K; Sugimoto S; Kanazawa A; Tokuka A; Ozaki N
    Gan To Kagaku Ryoho; 2004 May; 31(5):759-61. PubMed ID: 15170988
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A preliminary study of single intraperitoneal administration of paclitaxel followed by sequential systemic chemotherapy with S-1 plus paclitaxel for advanced gastric cancer with peritoneal metastasis.
    Imano M; Peng YF; Itoh T; Nishikawa M; Satou T; Yasuda A; Inoue K; Kato H; Shinkai M; Tsubaki M; Yasuda T; Imamoto H; Nishida S; Furukawa H; Takeyama Y; Okuno K; Shiozaki H
    Anticancer Res; 2012 Sep; 32(9):4071-5. PubMed ID: 22993363
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Treatment for advanced gastric cancer with positive lavage cytology-systemic versus intraperitoneal chemotherapy].
    Iwasaki Y; Ohashi M; Nunobe S; Iwanaga T; Iwagami S; Takahashi K; Yamaguchi T; Matsumoto H; Nakano D
    Gan To Kagaku Ryoho; 2008 Nov; 35(12):2009-11. PubMed ID: 19106506
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Clinical study of TS-1 for inoperative and recurrent gastric cancer and evaluation of long survival cases].
    Tanabe K; Yoshida K; Hamai Y; Ukon K; Ohta K; Hihara J; Toge T
    Gan To Kagaku Ryoho; 2005 Aug; 32(8):1145-8. PubMed ID: 16121917
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Outcome of therapy for type 4 gastric cancer with peritoneal metastasis--diagnosis by laparoscopy and effect of chemotherapy].
    Tamura S; Miki H; Okada K; Yoshimura M; Uji K; Yoshida A; Yoshioka Y; Suzuki R; Nakahira S; Egawa C; Nakata K; Okamura S; Sugimoto K; Takatsuka Y
    Gan To Kagaku Ryoho; 2009 Nov; 36(12):2000-2. PubMed ID: 20037304
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Retrospective analysis of treatment for advanced gastric cancer with peritoneal dissemination].
    Nakamura R; Saikawa Y; Wada N; Yoshida M; Kubota T; Kumai K; Kitajima M; Kitagawa Y
    Gan To Kagaku Ryoho; 2007 Nov; 34(11):1827-31. PubMed ID: 18030017
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Clinical evaluation, including QOL of TS-1 for patients with locally advanced or recurrent gastric cancer at ambulatory setting].
    Oeda M; Hirabayashi N; Takiyama W; Nagamine I; Ohara M; Oshita A; Satou Y; Saeki S; Kirihara Y; Mukaida H; Hisamatu K
    Gan To Kagaku Ryoho; 2003 Oct; 30(10):1453-8. PubMed ID: 14584277
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Multicenter phase II trial of S-1, paclitaxel and cisplatin triplet combination chemotherapy in patients with advanced gastric cancer.
    Kim JY; Do YR; Park KU; Kim JG; Chae YS; Kim MK; Lee KH; Ryoo HM; Bae SH; Baek JH; Song HS
    Cancer Chemother Pharmacol; 2011 Mar; 67(3):527-32. PubMed ID: 20461377
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Evaluation of pre-operative administration of TS-1 in patients with advanced gastric or colorectal cancer--estimation of pathological effectiveness for postoperative adjuvant chemotherapy with TS-1].
    Nakano K; Koizumi H; Okugawa K; Nakamura K; Osaka Y; Tsuchiya K; Sako H; Tanabe S; Nakane Y
    Gan To Kagaku Ryoho; 2005 Mar; 32(3):329-33. PubMed ID: 15791815
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [TS-1 and lentinan combination immunochemotherapy for advanced or recurrent gastric cancer: a preliminary report].
    Kimura Y; Iijima S; Kato T; Tsujie M; Naoi Y; Hayashi T; Tanigawa T; Yamamoto H; Kurokawa E; Matsuura N; Kikkawa N
    Gan To Kagaku Ryoho; 2003 Oct; 30(11):1791-3. PubMed ID: 14619521
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.